Results 181 to 190 of about 3,487 (207)

Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)

Multiple Sclerosis and Related Disorders, 2022
Christine Till, Brenda Banwell, Giulia Fadda   +2 more
exaly  

Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis

Journal of Neuroimmunology, 2022
Gaurav Nepal, Rajeev Ojha, Sanjeev Kharel   +2 more
exaly  

Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis

Multiple Sclerosis and Related Disorders, 2023
Wim van Hecke, Thibo Billiet, Itay Lotan   +2 more
exaly  

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

Journal of Neurology, 2023
Abdullah Al-Ani, John Chen, Fiona Costello   +2 more
exaly  

MOGAD features and outcomes

Journal of the Neurological Sciences, 2023
openaire   +1 more source

A rare but distinct and unique phenotype of MOGAD

Multiple Sclerosis Journal, 2022
openaire   +2 more sources

Drug refractory epilepsy in MOGAD: an evolving spectrum

Neurological Sciences, 2023
Ranjot Kaur, Rajesh Kumar Singh, Deepti Vibha, Shailesh Gaikwad, Manjari Tripathi   +4 more
openaire   +2 more sources

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

Frontiers in Neurology, 2022
Laura Cacciaguerra, Giulia Fadda, Alessandro Dinoto   +2 more
exaly  

Investigating the Immunopathogenic Mechanisms Underlying MOGAD

Annals of Neurology, 2021
Jennifer A. McCombe, Eoin P. Flanagan, John J. Chen, Anastasia Zekeridou, Claudia F. Lucchinetti, Sean J. Pittock   +5 more
openaire   +2 more sources

Emerging therapies for MOGAD/NMOSD

Journal of the Neurological Sciences, 2023
openaire   +1 more source